CollPlant Biotechnologies Ltd Research And Development Expense
CollPlant Biotechnologies Ltd (CLGN) reported Research And Development Expense of $4.41 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-01.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2020-04-01
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2018-06-30 was 2.33M ILS, a 45.67% decline year-over-year.
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2017-06-30 was 4.30M ILS.
ILS
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2018-12-31 | 16.21M ILS 20-F · filed 2019-04-01 | ||
| 2018-06-30 | 2.33M ILS 6-K · filed 2018-09-21 | 6.80M ILS 6-K · filed 2018-09-21 | |
| 2017-12-31 | 16.92M ILS 20-F · filed 2019-04-01 | ||
| 2017-06-30 | 4.30M ILS 6-K · filed 2018-09-21 | 8.34M ILS 6-K · filed 2018-09-21 | |
| 2016-12-31 | 29.20M ILS 20-F · filed 2019-04-01 | ||
| 2015-12-31 | 22.92M ILS 20-F · filed 2018-03-20 |
USD
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $4.41M 20-F · filed 2020-04-01 | |||||
| 2019-06-30 | $797.00K 6-K · filed 2019-09-26 | $1.67M 6-K · filed 2019-09-26 | ||||
| 2018-12-31 | $3.88M 20-F · filed 2020-04-01 | $4.33M 20-F · filed 2019-04-01 | ||||
| 2018-06-30 | $641.00K 6-K · filed 2019-09-26 | $591.00K 6-K · filed 2018-09-21 | $1.93M 6-K · filed 2019-09-26 | $1.86M 6-K · filed 2018-09-21 | ||
| 2017-12-31 | $3.91M 20-F · filed 2020-04-01 | $4.88M 20-F · filed 2018-03-20 |